Abstract: A carbon reduction assembly adapted for use with wet and dry coal combustion products (“CCPs”). The assembly includes a direct-fired carbon reduction section having a dry material inlet device that is adapted to receive the dry CCPs and a direct-fired carbon reduction section burner unit that is adapted to reduce carbon content in the dry CCPs. The assembly also includes a direct-fired dryer section that is operatively connected with the direct-fired carbon reduction section and has a wet material inlet device that is adapted to receive the wet CCPs and a direct-fired dryer section drum that is adapted to dry the wet CCPs. The assembly further includes a control unit that is operatively connected with the carbon reduction section and the dryer section. An amount of hot gas generated by the carbon reduction section is conveyed to the dryer section, and the assembly is adapted to produce dry fly ash.

Abstract: A carbon reduction assembly adapted for use with wet and dry coal combustion products (“CCPs”). The assembly includes a direct-fired carbon reduction section having a dry material inlet device that is adapted to receive the dry CCPs and a direct-fired carbon reduction section burner unit that is adapted to reduce carbon content in the dry CCPs. The assembly also includes a direct-fired dryer section that is operatively connected with the direct-fired carbon reduction section and has a wet material inlet device that is adapted to receive the wet CCPs and a direct-fired dryer section drum that is adapted to dry the wet CCPs. The assembly further includes a control unit that is operatively connected with the carbon reduction section and the dryer section. An amount of hot gas generated by the carbon reduction section is conveyed to the dryer section, and the assembly is adapted to produce dry fly ash.

Abstract: The invention relates to Substituted-Quinoxaline-Type Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound.

Abstract: The invention relates to Substituted-Quinoxaline-Type Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound.

Abstract: The invention relates to Substituted-Quinoxaline-Type Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound.

Abstract: The invention relates to Substituted-Quinoxaline-Type Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound.

Abstract: The invention relates to Substituted-Quinoxaline-Type Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound.

Abstract: A lockable container for an article comprises a frame which has an access opening, a closure member which is pivotally mounted in relation to the frame, and a latch member which is axially movable within the closure member between a latched position and an unlatched position. The latch member and the frame are each provided with one or more interengageable detents whereby when the closure member is in a closed position and the latch member is in the latched position the detents are engaged and prevent pivoting of the closure member. Movement of the latch member to the unlatched position causes the detents to disengage and permit pivoting of the closure member. The closure member is provided with a locking member for engaging the latch member to retain it against axial movement.

Abstract: A method of locking a container is shown, wherein the container is provided with a frame which has an access opening, a closure member which has two opposed long edges and two opposed short edges, and which is pivotally mounted in relation to the frame, and a latch member which is axially movable within the closure member between a latched position and an unlatched position. The latch member and the frame are each provided with one or more interengageable detents whereby when the closure member is in a closed position and the latch member is in the latched position the detents are engaged and prevent pivoting of the closure member. Movement of the latch member to the unlatched position causes the detents to disengage and permit pivoting of the closure member. The closure member is provided with a locking member for engaging the latch member to retain it against axial movement.

Abstract: The invention relates to Substituted-Quinoxaline-Type Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound.

Abstract: A lockable container for an article comprises a frame which has an access opening, a closure member which is pivotally mounted in relation to the frame, and a latch member which is axially movable within the closure member between a latched position and an unlatched position. The latch member and the frame are each provided with one or more interengageable detents whereby when the closure member is in a closed position and the latch member is in the latched position the detents are engaged and prevent pivoting of the closure member. Movement of the latch member to the unlatched position causes the detents to disengage and permit pivoting of the closure member. The closure member is provided with a locking member for engaging the latch member to retain it against axial movement.

Abstract: A lockable container for an article comprises a frame (2) which has an access opening (4), a closure member (10) which is pivotally mounted in relation to the frame (2), and a latch member (28) which is axially movable within the closure member (10) between a latched position and an unlatched position. The latch member (28) and the frame (2) are each provided with one or more interengageable detents (8, 34) whereby when the closure member (10) is in a closed position and the latch member (28) is in the latched position the detents (8, 34) are engaged and prevent pivoting of the closure member (10). Movement of the latch member (28) to the unlatched position causes the detents to disengage and permit pivoting of the closure member. The closure member (10) is provided with a locking member (22) for engaging the latch member (28) to retain it against axial movement.

Abstract: A compound of formula (wherein A, R1, R2, R6, m and n are disclosed herein) or a pharmaceutically acceptable salt thereof (a “Piperazine Compound”); pharmaceutical compositions comprising a Piperazine Compound; and methods for treating pain, urinary incontinence (UI), an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis (ALS), dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia and depression in an animal comprising administering to an animal in need thereof an effective amount of a Piperazine Compound are disclosed.

Abstract: Switchable two-fiber systems to provide a backup fiber link to a signal detector where the backup signal is switched to the signal detector when the primary signal fails.

Abstract: A compound of formula 1

Abstract: Controllable optical switches in response to feedback signals from optical position sensors that measure switch orientations. The optical position sensors may include local sensors that monitor and measure orientations of individual switches and global sensors that monitor and measure overall alignment of signal beams. Such switches may be used to form non-blocking switching arrays.

Abstract: Switchable two-fiber systems to provide a backup fiber link to a signal detector where the backup signal is switched to the signal detector when the primary signal fails.

Abstract: Techniques for using the same optical bandpass filter to add, drop, or exchange a WDM channel in a WDM device.

Abstract: The present invention provides a detent mechanism adapted to be mounted on a container which is to contain one or more articles, notably CD cases, which container has an access aperture through which the article(s) can be inserted into or moved from the container. The detent mechanism is adapted to retain the article within the container and is formed from a mounting member adapted to be carried externally in the container, preferably at or adjacent the access aperture of the container. A latch member is adapted to be carried externally of the container by the mounting member and is movable between a retracted position at which at least the distal end of which is adapted to retain an article within the container. The latch member is also movable to a extended position in which latch member permits removal of the article through the access aperture by being located out of the line of travel of the article as the article is withdrawn from the container.

Abstract: A process is provided for the recovery and reuse of a salt solution obtained from a salty effluent (as herein defined) comprising: (1) passing said salty effluent, optionally after removing any fine particles therefrom, through a membrane filtration system which separates the salt in the form of a salt solution from the food residues; (2) passing said salt solution through an evaporator to decrease the water content thereof; (3) adjusting the temperature of the salt solution, typically within the range 15.degree.-25.degree. C.